Research Article

A retrospective assessment of the oncological and clinical outcomes of nephrectomy performed due to renal mass

Volume: 7 Number: 2 June 30, 2026

A retrospective assessment of the oncological and clinical outcomes of nephrectomy performed due to renal mass

Abstract

To evaluate the clinical outcomes of nephrectomy performed due to renal mass. Cases of nephrectomy performed due to renal mass at the Samsun University Urology Department between 2015 and 2024 were assessed retrospectively through our database. The patients’ sociodemographic characteristics, pre- and postoperative clinical parameters, surgical techniques, pathology findings, and complications were recorded. One hundred seventy-seven patients with a mean age of 62.84 ± 12 years, 61.6% of whom were men, were included in the study. Radical nephrectomy was performed in 62.7% of cases, and partial nephrectomy in 37.3%. Laparoscopic surgical techniques were applied in 67% of the cases. The mean tumor size was 5.41 ± 2.91 cm, mean operative time was 172.18 ± 75.28 min, mean length of hospitalization was 6.42 ± 4.27 days, and time from diagnosis to treatment was 52.37 ± 5.21 days. Partial nephrectomy was superior to radical nephrectomy in terms of preserving kidney functions (p <0.001). Laparoscopic radical nephrectomy was associated with a shorter hospital stay (p <0.001) and a longer operative time (p <0.001). Partial nephrectomy effectively preserves oncological safety while protecting kidney functions in the surgical treatment of renal masses. Laparoscopic techniques are advantageous in terms of length of hospital stay and complication rates, but are associated with a longer operative time.

Keywords

References

  1. 1. Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol. 2016; 70(1):93-105.
  2. 2. Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018; 103:356-87.
  3. 3. Capitanio U, Bensalah K, Bex A, et al. Epidemiology of Renal Cell Carcinoma. Eur Urol. 2019; 75(1):74-84.
  4. 4. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality world wide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74(3):229-63.
  5. 5. Klatte T, Pantuck AJ. Molecular biology of renal cortical tumors. Urol Clin North Am. 2008; 35(4):573-80.
  6. 6. Cirillo L, Innocenti S, Becherucci F. Global epidemiology of kidney cancer. Nephrol Dial Transplant. 2024; 39(6):920-28.
  7. 7. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007; 57(1):43-66.
  8. 8. Levi F, Ferlay J, Galeone C, et al. The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int. 2008; 101(8):949-58.

Details

Primary Language

English

Subjects

Urology

Journal Section

Research Article

Publication Date

June 30, 2026

Submission Date

March 8, 2026

Acceptance Date

June 19, 2026

Published in Issue

Year 2026 Volume: 7 Number: 2

APA
Kayhan, M. E., Yıldırım, İ. Ö., Ordulu, R., Şengül, M., Küçük, E., Akdeniz, E., Ulubay, M., & Atilla, M. K. (2026). A retrospective assessment of the oncological and clinical outcomes of nephrectomy performed due to renal mass. New Trends in Medicine Sciences, 7(2), 38-46. https://doi.org/10.56766/ntms.1900284
AMA
1.Kayhan ME, Yıldırım İÖ, Ordulu R, et al. A retrospective assessment of the oncological and clinical outcomes of nephrectomy performed due to renal mass. New Trend Med Sci. 2026;7(2):38-46. doi:10.56766/ntms.1900284
Chicago
Kayhan, Muhammed Esad, İlayda Özden Yıldırım, Reha Ordulu, et al. 2026. “A Retrospective Assessment of the Oncological and Clinical Outcomes of Nephrectomy Performed Due to Renal Mass”. New Trends in Medicine Sciences 7 (2): 38-46. https://doi.org/10.56766/ntms.1900284.
EndNote
Kayhan ME, Yıldırım İÖ, Ordulu R, Şengül M, Küçük E, Akdeniz E, Ulubay M, Atilla MK (June 1, 2026) A retrospective assessment of the oncological and clinical outcomes of nephrectomy performed due to renal mass. New Trends in Medicine Sciences 7 2 38–46.
IEEE
[1]M. E. Kayhan et al., “A retrospective assessment of the oncological and clinical outcomes of nephrectomy performed due to renal mass”, New Trend Med Sci, vol. 7, no. 2, pp. 38–46, June 2026, doi: 10.56766/ntms.1900284.
ISNAD
Kayhan, Muhammed Esad - Yıldırım, İlayda Özden - Ordulu, Reha - Şengül, Mesut - Küçük, Emrah - Akdeniz, Ekrem - Ulubay, Mahmut - Atilla, M. Kemal. “A Retrospective Assessment of the Oncological and Clinical Outcomes of Nephrectomy Performed Due to Renal Mass”. New Trends in Medicine Sciences 7/2 (June 1, 2026): 38-46. https://doi.org/10.56766/ntms.1900284.
JAMA
1.Kayhan ME, Yıldırım İÖ, Ordulu R, Şengül M, Küçük E, Akdeniz E, Ulubay M, Atilla MK. A retrospective assessment of the oncological and clinical outcomes of nephrectomy performed due to renal mass. New Trend Med Sci. 2026;7:38–46.
MLA
Kayhan, Muhammed Esad, et al. “A Retrospective Assessment of the Oncological and Clinical Outcomes of Nephrectomy Performed Due to Renal Mass”. New Trends in Medicine Sciences, vol. 7, no. 2, June 2026, pp. 38-46, doi:10.56766/ntms.1900284.
Vancouver
1.Muhammed Esad Kayhan, İlayda Özden Yıldırım, Reha Ordulu, Mesut Şengül, Emrah Küçük, Ekrem Akdeniz, Mahmut Ulubay, M. Kemal Atilla. A retrospective assessment of the oncological and clinical outcomes of nephrectomy performed due to renal mass. New Trend Med Sci. 2026 Jun. 1;7(2):38-46. doi:10.56766/ntms.1900284